2019
DOI: 10.1007/s11882-019-0837-7
|View full text |Cite
|
Sign up to set email alerts
|

Direct to Consumer Telemedicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(19 citation statements)
references
References 13 publications
0
19
0
Order By: Relevance
“…Broadly, there are 2 models of eVisit (virtual visit) currently available in Canada and the United States—a pay per use model and an insured model. In a pay per use model, also referred to as Direct to Consumer, the consumer (patient and/or family) pays a fee to access a physician for a health care consultation through a virtual visit [33]. In the insured model, virtual visits are covered by private or public health insurance.…”
Section: Discussionmentioning
confidence: 99%
“…Broadly, there are 2 models of eVisit (virtual visit) currently available in Canada and the United States—a pay per use model and an insured model. In a pay per use model, also referred to as Direct to Consumer, the consumer (patient and/or family) pays a fee to access a physician for a health care consultation through a virtual visit [33]. In the insured model, virtual visits are covered by private or public health insurance.…”
Section: Discussionmentioning
confidence: 99%
“…With a home-based video interaction, the patient can have an interaction with a provider, who, in addition to obtaining a thorough history of symptoms and exposure risk, can perform an observational assessment. 11 This assessment should include the following:…”
Section: Home-based Video Encounters For Triagementioning
confidence: 99%
“…As allergy care (allergic rhinoconjunctivitis, sinusitis, asthma/bronchitis, rash) has been a particular focus of DtC telemedicine companies, there is significant potential for patients with allergies and asthma to seek care outside of the medical home. A concern about this trend is that most of the virtual allergy care through DtC telehealth platforms has been provided by nonallergists, which may have implications for adherence to evidence-based best practices [21].…”
Section: Direct-to-consumer (Dtc)mentioning
confidence: 99%